Components of Metabolic Syndrome and the Rising Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in the United States

被引：0
|
作者：
Stepanova, Maria
Afendy, Mariam
Vernon, Gregory C.
Nader, Fatema
Younossi, Zobair M.
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S988 / S988
页数：1
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [42] DIFFERENTIATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) FROM SIMPLE STEATOSIS: ASSESSMENT AND VALIDATION OF NOVEL METABOLIC MARKERS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) SEVERITY
    Goyale, A.
    Jain, A.
    Smith, C.
    Misas, M. Guerrero
    Roccarina, D.
    Buzzetti, E.
    Tsochatzis, E.
    Nair, D.
    ATHEROSCLEROSIS, 2018, 275 : E65 - E65
  • [43] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario
    Vigano, Luca
    Lleo, Ana
    Aghemo, Alessio
    HEPATOBILIARY SURGERY AND NUTRITION, 2018, 7 (02) : 130 - 133
  • [44] Non-alcoholic steatohepatitis: metabolic syndrome of the liver
    Day, C. P.
    PATHOGENESIS AND CLINICAL PRACTICE IN GASTROENTEROLOGY, 2008, 160 : 171 - 185
  • [45] Non-alcoholic fatty liver disease (NAFLD) after orthotopic liver transplantation (OLT) in patients with cryptogenic cirrhosis (CC) and non-alcoholic steatohepatitis (NASH)
    Amaro, R
    Montalbano, M
    Acosta, RC
    Concha, R
    Weppler, D
    Neff, GW
    O'Brien, CB
    Molina, EG
    Schiff, ER
    Tzakis, AG
    GASTROENTEROLOGY, 2001, 120 (05) : A118 - A118
  • [46] LDL:HDL Ratio as a Risk Factor for Non-Alcoholic Steatohepatitis (NASH) in Non-Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients
    Mitchell, Brittany
    Aggarwal, Manik
    McCullough, Arthur
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S544 - S545
  • [47] Prevalence of non-alcoholic fatty liver disease (NAFLD) in Singapore
    Tan, H. H.
    Chang, J. P. E.
    Chin, C.
    Tan, C. K.
    Lui, H. F.
    Chow, W. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A444 - A445
  • [48] Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Bifari, Francesco
    Manfrini, Roberto
    Cas, Michele Dei
    Berra, Cesare
    Siano, Matteo
    Zuin, Massimo
    Paroni, Rita
    Folli, Franco
    PHARMACOLOGICAL RESEARCH, 2018, 137 : 219 - 229
  • [49] Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review
    Laddha, Ankit P.
    Dzielak, Lindsey
    Lewis, Cedric
    Xue, Raymond
    Manautou, Jose E.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (03):
  • [50] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +
12345